AL-335: Phase I started

Achillion Pharmaceuticals Inc. (NASDAQ:ACHN, New Haven, Conn.) said Johnson & Johnson’s Janssen Biotech Inc. unit began an open-label, French Phase I trial to evaluate an oral, once-daily regimen of ...